And yet another biotech company is gobbled up. It's relentless
Who do you think has been sizing up Starpharma?
Clementia Pharmaceuticals (NASDAQ: CMTA) announced that it will be acquired by Ipsen (Euronext: IPN; ADR: IPSEY) for $25 per share in cash upfront or $1.04b, plus deferred payments on the achievement of a future regulatory milestone in the form of a contingent value right (CVR) of $6 per share upon FDA acceptance of the NDA filing for palovarotene for the treatment of Multiple Osteochondroma, representing an additional potential payment of $263m. Shares closed up 74% to $26.06.
And yet another biotech company is gobbled up. It's relentless...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
